The Endocrine Fellows Foundation (EFF) and the American Society for Bone and Mineral Research (ASBMR) are pleased to offer fellows training in osteoporosis and other metabolic bone diseases a unique opportunity to participate in a Fellows Forum on Metabolic Bone Diseases. This year the Fellows Forum will be held virtually the week prior to the 2021 ASBMR Annual Meeting, October 1-4.
Each day the Forum begins at 9:00 AM EDT and ends at 4:30 pm EDT. Preview the Agenda
The program format is a combination of plenary lectures and breakout sessions given by distinguished leaders in the field. This year's Faculty includes Dr. John Bilezikian, Dr. Teresita Bellido. Dr. Neil Binkley, Dr. Mary Bouxsein, Dr. Bart Clarke, Dr. Michael McClung, Dr. Paul Miller, Dr. Kristy Nicks, Dr. Clifford Rosen, Dr. Ego Seeman, Dr. Deborah Sellmeyer, and Dr. Michael Whyte. The topics selected for presentation and discussion are timely and among the most important in our field. There will be an equal balance of topics from both clinical and basic aspects of metabolic bone diseases.
The plenary lectures set the stage for the breakout sessions that are organized in such a way that clinical, translational, and basic aspects of the field are well represented. The breakout sessions are an opportunity for fellows to meet the experts and to learn more about areas in which they might already be interested or would like to become better informed.
Fellows are also invited to present their work in one of two poster sessions where they receive faculty and peer feedback. We view the poster session as one of the highlights of the day and look forward to hearing about fellows’ exciting research in this setting.
Directors of Postdoctoral Subspecialty Training Programs for MDs, Pre- or Postdoctoral PhD Fellowship Training Programs are invited to select individuals from their programs who meet the criteria and whose education, in their opinion, would be enhanced by participating in this Forum.
The focus of trainees in the three below categories must be in metabolic bone diseases but can be from any of the subspecialties (i.e., endocrinology, rheumatologic, basic bone biology, orthopedic research, geriatrics, etc.).
MD in an accredited, relevant specialty training program (1st, 2nd, or 3rd year)
PhD in a post-doctoral program (for not more than 3 years)
This educational activity is supported by unrestricted educational grants from: Amgen, Ultragenyx, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the American Society for Bone and Mineral Research (ASBMR).